Figure 4.
Percent body and organ weights in adult C57BL/6 mice following 2 weeks of anti-VEGF treatment relative to control-treated groups. (A) Percent organ and total body weights of C57BL/6 mice aged 14 weeks treated with mFlt(1-3)-IgG (n = 7). (B) C57BL/6 mice aged 16 weeks treated with G6-23-IgG (n = 5). Data represents mean ± standard deviation. Data are from 1 representative of 2 independent experiments.